This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2023 Oct 25;189(5):e81.

doi: 10.1093/bjd/ljad340.

Correction to: Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study

No authors listed

PMID: 37740959
DOI: 10.1093/bjd/ljad340

Published Erratum

Correction to: Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study

No authors listed. Br J Dermatol. 2023.

. 2023 Oct 25;189(5):e81.

doi: 10.1093/bjd/ljad340.

PMID: 37740959
DOI: 10.1093/bjd/ljad340

No abstract available

PubMed Disclaimer

Erratum for

Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study.
Landis MN, Smith SR, Berstein G, Fetterly G, Ghosh P, Feng G, Pradhan V, Aggarwal S, Banfield C, Peeva E, Vincent MS, Beebe JS, Tarabar S. Landis MN, et al. Br J Dermatol. 2023 Jul 7;189(1):33-41. doi: 10.1093/bjd/ljad098. Br J Dermatol. 2023. PMID: 36972293 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems